Latest Asx News

White Cliff Minerals has identified multiple high-priority copper targets along the 10km Teshierpi Fault Zone at its Rae Copper Project in Nunavut, Canada, following a comprehensive 2025 airborne electromagnetic survey. The findings extend known mineralisation at Danvers and set the stage for follow-up drilling in early 2026.

Prairie Lithium has completed critical groundwork at its Canadian lithium brine project, setting the stage for construction and commercial operations in 2026 amid rising lithium prices.

Transurban Group has announced a 34.0 cents per stapled security interim distribution for the half-year ending December 2025, maintaining its FY26 distribution guidance at 69.0 cents. The Distribution Reinvestment Plan will operate without a discount, signaling steady confidence amid ongoing macroeconomic uncertainties.

Microba Life Sciences has secured a $3.06 million R&D tax incentive refund for FY25, reinforcing its cash reserves and supporting ongoing advancements in gastrointestinal diagnostics and clinical therapeutics.

Phoslock Environmental Technologies is set to resume production at its Changxing factory after a four-year halt, signaling renewed confidence in market demand and operational stability.

QuickFee Limited has completed a $28.5 million capital return following the sale of its US Pay Now and Connect businesses, while updating its dividend policy to target regular shareholder cash distributions starting in FY26.

Invion Limited has expanded its global rights to the Photosoft™ technology, gaining exclusive perpetual licenses across a broad range of human and animal diseases, including cancers and infectious diseases. This milestone-based deal positions Invion to accelerate clinical development and commercialisation worldwide.

Odyssey Gold has reported strong reverse circulation drilling results at its Tuckanarra Project, reinforcing the existing resource model and advancing plans for a resource upgrade. The Highway Deposit continues to demonstrate promising grade continuity and open pit potential.

Island Pharmaceuticals has secured over $1 million through option exercises by directors and major shareholders, bolstering its cash reserves to advance the clinical and regulatory development of its broad-spectrum antiviral, Galidesivir.

Hazer Group has extended its collaboration with South Korean steel giant POSCO to further integrate its clean hydrogen and low-emissions graphite technology into low-carbon steel production.

Cobre Limited has confirmed the continuity of higher-grade copper-silver mineralisation at its Cosmos Target within Botswana’s Ngami Copper Project, prompting an extension of its drilling program to further delineate the resource.

Optiscan Imaging Ltd has initiated Australia’s first intra-operative head and neck cancer imaging study using its advanced InVue® and InForm™ devices, aiming to enhance surgical precision and support FDA regulatory submissions.